Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders

• Published in: International journal of molecular sciences 2024-12, Vol.25 (24), p.13465
• Main Authors: Fraser, Karl, James, Shanalee C, Young, Wayne, Gearry, Richard B, Heenan, Phoebe E, Keenan, Jacqueline I, Talley, Nicholas J, McNabb, Warren C, Roy, Nicole C
• Format: Article
• Language: English
• Subjects: Amino acids; Annotations; Constipation; Diarrhea; Irritable bowel syndrome; Lipids; Metabolism; Metabolites; Microbiota; Plasma
• ISSN: 1661-6596; 1422-0067
• DOI: 10.3390/ijms252413465

There is evidence of perturbed microbial and host processes in the gastrointestinal tract of individuals with functional gastrointestinal disorders (FGID) compared to healthy controls. The faecal metabolome provides insight into the metabolic processes localised to the intestinal tract, while the plasma metabolome highlights the overall perturbances of host and/or microbial responses. This study profiled the faecal (n = 221) and plasma (n = 206) metabolomes of individuals with functional constipation (FC), constipation-predominant irritable bowel syndrome (IBS-C), functional diarrhoea (FD), diarrhoea-predominant IBS (IBS-D) and healthy controls (identified using the Rome Criteria IV) using multimodal LC-MS technologies. Discriminant analysis separated patients with the ‘all constipation’ group (FC and IBS-C) from the healthy control group and ‘all diarrhoea’ group (FD and IBS-D) from the healthy control group in both sample types. In plasma, almost all multimodal metabolite analyses separated the ‘all constipation’ or ‘all diarrhoea’ group from the healthy controls, and the IBS-C or IBS-D group from the healthy control group. Plasma phospholipids and metabolites linked to several amino acid and nucleoside pathways differed (p < 0.05) between healthy controls and IBS-C. In contrast, metabolites involved in bile acid and amino acid metabolism were the key differentiating classes in the plasma of subjects with IBS-D from healthy controls. Faecal lipids, particularly ceramides, diglycerides, and triglycerides, varied (p < 0.05) between healthy controls and the ‘all constipation’ group and between healthy controls and ‘all diarrhoea’ group. The faecal and plasma metabolomes showed perturbations between constipation, diarrhoea and healthy control groups that may reflect processes and mechanisms linked to FGIDs.